Quick Answer
Twin pregnancy is a high-yield NEET PG obstetrics chapter — chorionicity, TTTS, delivery timing, and Indian ART trends dominate. Fix these:
- Chorionicity beats zygosity — determined by first-trimester ultrasound; almost 100 percent accurate at 11 to 14 weeks.
- Lambda (twin-peak) sign — dichorionic; T sign — monochorionic.
- Timing of MZ split — day 0 to 3 DCDA, 4 to 8 MCDA, 9 to 12 MCMA, over 13 conjoined.
- All dizygotic twins are dichorionic; monozygotic can be any type.
- TTTS — MCDA only; laser ablation of anastomoses 16 to 26 weeks (stages II to IV).
- DCDA deliver 37 to 38 weeks, MCDA 36 to 37 weeks, MCMA 32 to 34 weeks.
- First twin vertex — offer vaginal; first twin non-vertex or MCMA — caesarean.
- ART is the leading driver of rising twin rates in India.
- Monochorionic anomaly scan is doubled — TTTS surveillance every 2 weeks from 16 weeks; fetal echo at 20 to 22 weeks.
- Preeclampsia risk 2 to 3-fold, PPH from uterine over-distension, and preterm delivery in about 60 percent of twins.
Twin pregnancy is a compulsory read for NEET PG obstetrics — chorionicity classification, monochorionic-specific complications, delivery timing and Indian-specific ART trends recur in almost every recent paper. This deep dive walks through zygosity, chorionicity, surveillance, TTTS, delivery decisions, and the traps that catch candidates.
Zygosity versus chorionicity
- Zygosity — biological origin. Monozygotic (MZ, identical) twins arise from a single fertilised ovum that then divides; they share genotype. Dizygotic (DZ, non-identical) twins arise from two separate fertilised ova; they are as genetically related as ordinary siblings.
- Chorionicity — placental architecture. Depends, for MZ twins, on the timing of division:
- Day 0 to 3 (before morula) — dichorionic diamniotic (DCDA), two placentas, two chorions, two amnions.
- Day 4 to 8 (blastocyst) — monochorionic diamniotic (MCDA), one placenta, one chorion, two amnions.
- Day 9 to 12 (after amnion forms) — monochorionic monoamniotic (MCMA), one shared amnion.
- After day 13 — conjoined twins.
- All DZ twins are DCDA. MZ twins can be DCDA (about a third), MCDA (about two-thirds), MCMA (rare, 1 percent) or conjoined (extremely rare).
Determination of chorionicity
- First-trimester ultrasound (11 to 14 weeks) — approaches 100 percent accuracy.
- Lambda / twin-peak sign — a triangular projection of chorionic tissue between the two amniotic sacs indicates dichorionicity.
- T sign — thin inter-twin membrane meeting the placenta at a right angle, no intervening chorion — indicates monochorionicity.
- After 16 weeks accuracy falls; membrane thickness, sex concordance and placental counts are backup indicators.
- Discordant sex proves dizygosity and therefore dichorionicity.
Risk factors and rising incidence
- Assisted reproductive technology (ART) — IVF and controlled ovarian stimulation is now the leading cause of rising twin rates worldwide and in India; elective single embryo transfer policies are reducing this again.
- Advanced maternal age — dizygotic rates rise sharply after 35.
- High parity and family history of DZ twins (maternal side).
- Ethnicity — African populations have the highest DZ rates; Asian populations the lowest; monozygotic rates are constant globally.
- Discontinuation of oral contraception and taller/heavier body habitus are minor associations.
Maternal complications
- Hyperemesis gravidarum from higher hCG.
- Gestational hypertension and preeclampsia (2 to 3-fold increase).
- Gestational diabetes.
- Iron-deficiency anaemia.
- Placenta praevia and abruption.
- Polyhydramnios.
- Preterm labour and PROM.
- Postpartum haemorrhage from uterine over-distension.
- Higher operative delivery (assisted vaginal, caesarean).
Fetal and neonatal complications
- Preterm delivery — about 60 percent of twins deliver before 37 weeks.
- Intrauterine growth restriction and low birth weight.
- Congenital anomalies — roughly doubled compared with singletons; cardiac defects particularly common in monochorionic pairs.
- Stillbirth and neonatal death rates elevated.
- Long-term neurodevelopmental morbidity — cerebral palsy risk elevated four to six-fold.
Monochorionic-specific complications
Twin-twin transfusion syndrome (TTTS)
- MCDA only, roughly 10 to 15 percent.
- Unbalanced arterio-venous anastomoses shunt blood from donor to recipient.
- Donor — hypovolaemia, oliguria, oligohydramnios, IUGR (stuck twin).
- Recipient — hypervolaemia, polyuria, polyhydramnios, cardiomegaly, hydrops.
- Quintero staging I to V drives management.
- Fetoscopic laser photocoagulation of the anastomoses at 16 to 26 weeks for stages II to IV — best survival benefit.
- Amnioreduction — symptom relief when laser unavailable.
- Untreated stage III to IV TTTS mortality approaches 90 percent.
Selective growth restriction (sGR)
- Estimated fetal weight discordance more than 25 percent with one twin below the 10th centile.
- Classified I, II, III by umbilical artery Doppler pattern.
- Surveillance frequency and delivery timing tailored to type.
Twin anaemia-polycythaemia sequence (TAPS)
- Chronic slow inter-twin transfusion through small anastomoses without amniotic fluid discordance.
- Screen with middle cerebral artery peak systolic velocity from about 20 weeks.
Twin reversed arterial perfusion (TRAP) sequence
- Acardiac twin perfused retrogradely by the pump twin.
- Radiofrequency ablation of the acardiac twin's cord to protect the pump twin.
MCMA cord entanglement
- Universal in MCMA — the shared sac allows cords to knot and compress.
- Drives the deliberately early scheduled delivery at 32 to 34 weeks after antenatal corticosteroids.
Antenatal surveillance schedule
- Dating and chorionicity ultrasound by 14 weeks — the single most important scan of the pregnancy.
- Detailed anomaly scan at 20 weeks.
- DCDA growth ultrasound every 4 weeks from 20 weeks.
- MCDA growth and Doppler every 2 weeks from 16 weeks (TTTS, TAPS surveillance) plus fetal echo at 20 to 22 weeks.
- MCMA intensive monitoring from 26 to 28 weeks (often inpatient) with CTG two to three times daily.
- NST and BPP in the third trimester for all twin pregnancies.
- Preeclampsia and preterm labour screening throughout.
Delivery timing and mode
Timing (uncomplicated)
- DCDA — 37 to 38 weeks.
- MCDA — 36 to 37 weeks.
- MCMA — 32 to 34 weeks after antenatal corticosteroids.
- Complicated pregnancies (TTTS, sGR, preeclampsia) deliver earlier, driven by the specific pathology.
Mode
- First twin vertex, no other contraindication, experienced obstetrician — offer vaginal delivery.
- First twin non-vertex (breech or transverse), MCMA, or higher-order (triplets or more) — planned caesarean.
- Second twin after vaginal delivery of the first — options are continuing vertex vaginal delivery, internal podalic version with total breech extraction (for non-vertex second twin), or emergency caesarean if malposition or fetal distress.
- Combined delivery (vaginal for twin 1, caesarean for twin 2) is a well-recognised outcome and not a failure.
India-specific context
- ART-driven rise — twin and higher-order pregnancies have risen sharply with the expansion of IVF and IUI clinics; national ART regulation now emphasises embryo-transfer limits.
- PMJAY / Ayushman Bharat covers caesarean delivery in empanelled hospitals, improving access for higher-risk twin deliveries.
- First-trimester chorionicity ultrasound is under-used in primary care — many twin pregnancies present late and chorionicity is inferred from placental appearance, losing accuracy.
- Selective fetal reduction in higher-order ART pregnancies (from triplets or more to twins) is offered at tertiary centres and remains ethically debated.
- Tertiary NICU capacity for MCMA and very preterm twins is concentrated in metros — antenatal transfer to a Level 3 unit before 32 weeks is standard of care.
- Perinatal mortality for twins remains higher in India than in high-income countries, largely driven by preterm delivery and limited NICU beds.
NEET PG MCQ traps
- Lambda / twin-peak sign — dichorionic.
- T sign — monochorionic.
- Day 4 to 8 monozygotic split — MCDA.
- Day over 13 split — conjoined twins.
- All dizygotic twins are dichorionic.
- Best time for chorionicity determination — 11 to 14 weeks.
- TTTS — MCDA only, laser at 16 to 26 weeks stages II to IV.
- Quintero stage I — poly-oligohydramnios sequence alone; expectant management often chosen.
- DCDA delivery — 37 to 38 weeks.
- MCMA delivery — 32 to 34 weeks after corticosteroids.
- MCMA delivery mode — planned caesarean.
- First twin breech — planned caesarean.
- TRAP sequence — acardiac twin, radiofrequency ablation.
- TAPS — MCA peak systolic velocity discordance without polyhydramnios/oligohydramnios discordance.
- PPH in twins from uterine over-distension.
- Preeclampsia risk 2 to 3-fold in twin pregnancy.
- Anaemia more common (iron and folate demands doubled).
- ART — leading contemporary driver of rising twin rates.
- Perinatal mortality monochorionic more than 2 to 3-fold dichorionic.
- Selective growth restriction type II or III — reversed or absent end-diastolic flow, elective preterm delivery.
Frequently asked questions
What is the difference between zygosity and chorionicity, and how is chorionicity determined?
Zygosity refers to the origin of the pregnancy — monozygotic (identical, single fertilised ovum that then splits) or dizygotic (non-identical, two separately fertilised ova). Chorionicity refers to the placental architecture — dichorionic diamniotic (DCDA, two placentas or two chorionic sacs and two amniotic sacs), monochorionic diamniotic (MCDA, one placenta and chorion but two amniotic sacs), monochorionic monoamniotic (MCMA, one placenta, one chorion, one amniotic sac), and rarely conjoined twins. All dizygotic twins are dichorionic. Monozygotic twins can be DCDA, MCDA, MCMA or conjoined depending on when division occurs — day 0 to 3 gives DCDA, day 4 to 8 gives MCDA, day 9 to 12 gives MCMA, and after day 13 gives conjoined twins. Chorionicity is best determined by first-trimester ultrasound (11 to 14 weeks) with almost 100 percent accuracy — the lambda or twin-peak sign (a thick wedge of chorionic tissue extending between the amniotic sacs) indicates dichorionicity, and the T sign (thin inter-twin membrane meeting the placenta at a right angle with no intervening chorion) indicates monochorionicity. After 16 weeks, membrane count and fetal sex become less reliable.
What is twin-twin transfusion syndrome (TTTS) and how is it managed?
TTTS is a serious complication unique to monochorionic diamniotic (MCDA) twin pregnancies, occurring in about 10 to 15 percent. Unbalanced arterio-venous placental anastomoses shunt blood from one twin (donor) to the other (recipient). The donor becomes hypovolaemic, oliguric and growth-restricted with oligohydramnios (a stuck twin appearance), while the recipient becomes hypervolaemic and polyuric with polyhydramnios and, when severe, hydrops fetalis and cardiac failure. Diagnosis is by serial ultrasound — the Quintero staging system classifies TTTS from stage I (poly-oligo sequence alone) to stage V (demise of one or both twins). The mainstay of treatment for stages II to IV between 16 and 26 weeks is fetoscopic laser photocoagulation of the placental anastomoses, which improves survival of at least one twin to about 70 to 90 percent. Amnioreduction can offer symptomatic relief when laser is unavailable. Untreated TTTS carries about 90 percent mortality. Both twins require careful neurodevelopmental follow-up because in-utero shunting predisposes to periventricular leukomalacia and cerebral palsy.
How is the timing and mode of delivery decided for the different chorionicity subtypes?
For uncomplicated DCDA twins, delivery is planned at 37 to 38 weeks; for uncomplicated MCDA twins at 36 to 37 weeks; and for MCMA twins at 32 to 34 weeks (typically after a course of antenatal corticosteroids) because of the risk of unpredictable cord entanglement. Complicated pregnancies deliver earlier, guided by the specific pathology. Mode of delivery — vaginal delivery is offered if the first twin is vertex, there is no other obstetric contraindication, an experienced obstetrician is available, and facilities for immediate caesarean exist. If the first twin is non-vertex (breech or transverse), if the pregnancy is monoamniotic, or if the pregnancy is higher-order (triplets or more), caesarean section is the default. For the second twin after vaginal delivery of the first, options include continuing spontaneous vertex delivery, internal podalic version with total breech extraction (for a non-vertex second twin), or emergency caesarean if malposition or fetal distress supervenes.
Why has the incidence of twin pregnancy risen in India and what are the maternal and fetal risks?
The incidence of twin and higher-order pregnancy has risen sharply in India in the last two decades, driven mostly by assisted reproductive technology (IVF, IUI with ovulation induction), older maternal age at conception, and higher parity. Naturally-occurring dizygotic twinning is also more common in African than in Asian populations. Maternal risks are substantially elevated compared to a singleton pregnancy — hyperemesis gravidarum, gestational hypertension and preeclampsia (2 to 3-fold), gestational diabetes, iron deficiency anaemia, placenta praevia and abruption, polyhydramnios, preterm labour, PPH from uterine over-distension, and higher operative delivery rates. Fetal risks include preterm delivery (about 60 percent of twins deliver before 37 weeks), intrauterine growth restriction, congenital anomalies (roughly double the singleton rate, particularly cardiac in monochorionic pairs), stillbirth, neonatal death, and long-term neurodevelopmental impairment. Monochorionic-specific risks — TTTS, selective growth restriction, twin anaemia-polycythaemia sequence (TAPS), twin reversed arterial perfusion (TRAP) sequence, and cord entanglement in MCMA. India-specific issues include underuse of first-trimester chorionicity ultrasound, high preterm delivery rates and limited tertiary NICU access outside metros.
What ultrasound surveillance schedule is recommended for monochorionic and dichorionic twin pregnancies?
Chorionicity should be established by 14 weeks. For dichorionic diamniotic (DCDA) twins, growth ultrasounds are performed every 4 weeks from 20 weeks onwards, with a detailed anomaly scan at 20 weeks. For monochorionic diamniotic (MCDA) twins, growth and Doppler ultrasound is performed every 2 weeks from 16 weeks onwards to screen for TTTS (deepest vertical pocket for oligo/polyhydramnios, middle cerebral artery peak systolic velocity for TAPS from about 20 weeks), plus fetal echocardiography around 20 to 22 weeks because of higher cardiac anomaly rates. Monochorionic monoamniotic (MCMA) twins are usually managed inpatient or with intensive outpatient surveillance from 26 to 28 weeks with cardiotocography two to three times daily until scheduled delivery at 32 to 34 weeks. In the third trimester all twin pregnancies receive antenatal testing (NST and biophysical profile), with earlier and more frequent monitoring for any suspicion of preeclampsia, IUGR or discordant growth.
This content is for educational purposes for NEET PG exam preparation. It is not a substitute for professional medical advice, diagnosis, or treatment. Clinical information has been reviewed by qualified medical professionals.
Written by: NEETPGAI Editorial Team
Reviewed by: Pending SME Review
Last reviewed: September 2026
